IDO1 is expressed on both cancer cells and myeloid cells within the tumor microenvironment, where it elevates the level of kynurenine, an immunosuppressive metabolite, while depleting tryptophan, a vital nutrient for effector cells, including cytotoxic T lymphocytes (CTLs) (16). Here, IDO1 is linked to cancer.